Dr Laura Broughton

Validation of the HULL Score clinical prediction rule for unsuspected pulmonary embolism in ambulatory cancer patients

Haque, F., Ryde, J., Broughton, L., Huang, C., Sethi, S., Stephens, A., Pillai, A., Mirza, S., Brown, V., Avery, G., Bozas, G., & Maraveyas, A. (2023). Validation of the HULL Score clinical prediction rule for unsuspected pulmonary embolism in ambulatory cancer patients. ERJ Open Research, 9(3), Article 00651-2022. https://doi.org/10.1183/23120541.00651-2022

Duramycin-porphyrin conjugates for targeting of tumour cells using photodynamic therapy

Broughton, L. J., Giuntini, F., Savoie, H., Bryden, F., Boyle, R. W., Maraveyas, A., & Madden, L. A. (2016). Duramycin-porphyrin conjugates for targeting of tumour cells using photodynamic therapy. Journal of photochemistry and photobiology. B, Biology, 163, 374-384. https://doi.org/10.1016/j.jphotobiol.2016.09.001

Duramycin-induced calcium release in cancer cells

Broughton, L. J., Crow, C., Madden, L. A., & Maraveyas, A. (2016). Duramycin-induced calcium release in cancer cells. Anti-cancer drugs, 27(3), 173-182. https://doi.org/10.1097/cad.0000000000000313

Targeting phosphatidylethanolamine on tumour cells using duramycin

Broughton, L. Targeting phosphatidylethanolamine on tumour cells using duramycin. Presented at 7th International Conference on Thrombosis and Hemostasis Issues in Cancer, Bergamo, Italy